Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China
· Delayed Price · Currency is CNY 23.54
+0.57 (2.48%)
At close: Mar 10, 2026
Jiangsu CoWin Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 2,588 | 2,620 | 3,180 | 3,429 | 3,314 | - | Upgrade
|
| Market Cap Growth | -8.90% | -17.61% | -7.26% | 3.44% | - | - | Upgrade
|
| Enterprise Value | 2,018 | 2,050 | 2,576 | 2,245 | 2,963 | - | Upgrade
|
| Last Close Price | 23.54 | 23.83 | 28.61 | 30.55 | 29.10 | - | Upgrade
|
| PE Ratio | - | - | - | - | 20.81 | - | Upgrade
|
| Forward PE | - | 21.80 | 21.80 | 21.80 | - | - | Upgrade
|
| PS Ratio | 13.40 | 13.57 | 25.26 | 20.01 | 6.35 | - | Upgrade
|
| PB Ratio | 1.84 | 1.86 | 2.14 | 2.04 | 1.85 | - | Upgrade
|
| P/TBV Ratio | 1.93 | 1.95 | 2.25 | 2.10 | 1.90 | - | Upgrade
|
| P/FCF Ratio | - | - | - | - | 474.27 | - | Upgrade
|
| P/OCF Ratio | - | - | - | - | 30.87 | - | Upgrade
|
| EV/Sales Ratio | 10.45 | 10.62 | 20.46 | 13.10 | 5.68 | - | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 15.62 | - | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 16.80 | - | Upgrade
|
| EV/FCF Ratio | - | - | - | - | 424.05 | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.07 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.20 | 0.27 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 5.84 | 1.99 | Upgrade
|
| Net Debt / Equity Ratio | -0.42 | -0.42 | -0.47 | -0.57 | -0.78 | -0.59 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.71 | 7.71 | 4.35 | 8.21 | -7.34 | -2.31 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 4.36 | 5.56 | -199.38 | -15.97 | Upgrade
|
| Asset Turnover | - | - | 0.07 | 0.09 | 0.40 | 0.62 | Upgrade
|
| Inventory Turnover | - | - | 1.61 | 1.60 | 3.77 | 3.34 | Upgrade
|
| Quick Ratio | - | - | 9.24 | 12.29 | 16.79 | 6.59 | Upgrade
|
| Current Ratio | - | - | 9.92 | 12.78 | 17.46 | 7.25 | Upgrade
|
| Return on Equity (ROE) | -7.13% | -7.13% | -10.20% | -4.83% | 14.58% | 26.16% | Upgrade
|
| Return on Assets (ROA) | - | - | -6.93% | -4.61% | 8.47% | 14.95% | Upgrade
|
| Return on Invested Capital (ROIC) | -12.77% | -13.09% | -25.25% | -24.73% | 49.24% | 67.26% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | -12.40% | -8.00% | 9.50% | 22.30% | Upgrade
|
| Earnings Yield | -3.99% | -3.94% | -4.94% | -2.46% | 4.81% | - | Upgrade
|
| FCF Yield | - | - | -5.08% | -4.99% | 0.21% | - | Upgrade
|
| Dividend Yield | - | - | - | - | 1.49% | - | Upgrade
|
| Buyback Yield / Dilution | 1.45% | 1.45% | 0.93% | -21.20% | -10.07% | -20.59% | Upgrade
|
| Total Shareholder Return | 1.45% | 1.45% | 0.93% | -21.20% | -8.58% | -20.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.